{
    "nctId": "NCT03126214",
    "officialTitle": "Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing: Program for the Identification of 'Actionable' AF (PIAAF) Rx Study",
    "inclusionCriteria": "* Age \u2265 65 years with one additional stroke risk factor (hypertension, diabetes, heart failure history of or left ventricular ejection fraction \\<0.40), previous stroke or transient ischemic attack).\n* Atrial fibrillation and not on oral anticoagulation (OAC) therapy but eligible\n* Atrial fibrillation on sub-optimal OAC\n* Must have minimum age of 65 Years",
    "exclusionCriteria": "* Uncontrolled hypertension (defined as average SBP \u2265 160 mmHg \\[2 readings taken at time of screening\\]).\n* End stage renal disease (CrCl \\< 15 ml/min)\n* Valvular Heart Disease including those with prosthetic valve, mitral stenosis (moderate to severe) or valve repair.\n* Excess alcohol intake (males: \u2265 28 units/week, females: \u2265 21 units/week. One unit of alcohol = 8 oz beer, 1 oz hard liquor or 4 oz wine).\n* Intracranial bleed at any point.\n* History of \"Major Bleeding\" at any point (defined as overt bleeding at a critical site including intracranial, intraspinal, intraocular, pericardial, or retroperitoneal; or bleed requiring hospitalization).\n* Foreshortened life-expectancy or severe comorbidities precluding study follow-up period\n* Unable to read/understand English\n* Severe cognitive impairment (defined as score \u2265 5 on the Short Portable Mental Status Questionnaire)"
}